Sales rise 11.57% to Rs 1951.14 crore
Net Loss of Piramal Pharma reported to Rs 88.64 crore in the quarter ended June 2024 as against net loss of Rs 98.58 crore during the previous quarter ended June 2023. Sales rose 11.57% to Rs 1951.14 crore in the quarter ended June 2024 as against Rs 1748.85 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales1951.141748.85 12 OPM %10.487.57 -PBDT139.4766.50 110 PBT-45.08-107.11 58 NP-88.64-98.58 10Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
